• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    AskBio Completes Enrollment in Phase 2 Heart Failure Trial

    GLOBENEWSWIRE

    AskBio`s AB-1005, AB-1002 Earn Japan Sakigake Status

    GLOBENEWSWIRE

    Askbio Publishes 12-Month Phase 1 AB-1002 Gene Therapy Trial

    GLOBENEWSWIRE

    Bayer Advances Gene And Cell Therapy Pipeline For Parkinson

    ECONOMICTIMES

    AskBio Reports Interim Safety Ph1/2 Results for AB-1003 in LGMD

    GLOBENEWSWIRE

    AskBio to Present Six Studies at ESGCT 2025 Annual Meeting

    GLOBENEWSWIRE

    Askbio Initiates Phase 2 Trial Of Ab-1005 For Parkinson`s

    GLOBENEWSWIRE

    AskBio Shares Ph1b Results for AB-1005 in Parkinson

    GLOBENEWSWIRE

    Belief BioMed Collaborates with AskBio on New Gene Therapies

    PR NEWSWIRE

    FDA grants fast track designation to AskBio’s AB-1005 for PD

    PHARMACEUTICAL-TECHNOLOGY

    AskBio Begins Recruitment for Phase 2 Trial of AB-1005 for Parkinson’s

    PHARMABIZ

    First patient in AskBio Phase II gene therapy trial for congestive heart failure

    PRESS RELEASE

    Bayer and AskBio reveal early safety data for Parkinson`s gene therapy

    ENDPTS

    AskBio announces first patient randomized in Phase 1 Trial of AB-1005

    INDIAN PHARMA POST

    AskBio Presents Preliminary Data from Phase 1 Trial of Gene Therapy for CHF

    PRESS RELEASE

    AskBio Contribution to Advancing Gene Therapy Highlighted at ESGCT 30th Congress

    PR NEWSWIRE

    AskBio Announces First Patient Dosed in Phase 1 / Phase 2 Trial of AB-1003

    PR NEWSWIRE

    AskBio announces 11 presentations offering insights into R&D of AAV therapies

    PHARMABIZ

    TAAV launches new corporate brand as a reflection of its transformation

    PR NEWSWIRE

    AskBio to Present Ph1b Results Investigating AB-1005 for Parkinson`s Disease

    PR NEWSWIRE

    AskBio to Collaborate with ReCode for Single Vector Gene Editing Platform

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.